CARDLYTICS INC - NOTE 1.000% 9/1

CUSIP: 14161WAB1

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
56.47%
Total 13F principal
$225,526,000
Principal change
-$4,053,000
Total reported market value
$126,796,674
Number of holders
10
Value change
-$2,293,110
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 14161WAB1?
CUSIP 14161WAB1 identifies 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q2 2023

As of 30 Jun 2023, CARDLYTICS INC - NOTE 1.000% 9/1 was held by 10 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $225,526,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, 683 Capital Management, LLC, Royal Bank of Canada, GABELLI FUNDS LLC, WELLINGTON MANAGEMENT GROUP LLP, Teton Advisors, Inc., and GAMCO INVESTORS, INC. ET AL. This page lists 10 institutional bondholders reporting positions for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.